BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18363832)

  • 41. Importance of endothelial Hey1 expression for thoracic great vessel development and its distal enhancer for Notch-dependent endothelial transcription.
    Watanabe Y; Seya D; Ihara D; Ishii S; Uemoto T; Kubo A; Arai Y; Isomoto Y; Nakano A; Abe T; Shigeta M; Kawamura T; Saito Y; Ogura T; Nakagawa O
    J Biol Chem; 2020 Dec; 295(51):17632-17645. PubMed ID: 33454003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The NOTCH1-HEY1 pathway regulates self-renewal and epithelial-mesenchymal transition of salivary adenoid cystic carcinoma cells.
    Xie J; Lin LS; Huang XY; Gan RH; Ding LC; Su BH; Zhao Y; Lu YG; Zheng DL
    Int J Biol Sci; 2020; 16(4):598-610. PubMed ID: 32025208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
    Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
    Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
    [No Abstract]   [Full Text] [Related]  

  • 44. CKAP2L Knockdown Exerts Antitumor Effects by Increasing miR-4496 in Glioblastoma Cell Lines.
    Li YF; Tsai WC; Chou CH; Huang LC; Huang SM; Hueng DY; Tsai CK
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of angiogenesis related factors in glioblastoma, peritumoral tissue and their derived cancer stem cells.
    D'Alessio A; Proietti G; Lama G; Biamonte F; Lauriola L; Moscato U; Vescovi A; Mangiola A; Angelucci C; Sica G
    Oncotarget; 2016 Nov; 7(48):78541-78556. PubMed ID: 27705944
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme.
    Daniele S; La Pietra V; Piccarducci R; Pietrobono D; Cavallini C; D'Amore VM; Cerofolini L; Giuntini S; Russomanno P; Puxeddu M; Nalli M; Pedrini M; Fragai M; Luchinat C; Novellino E; Taliani S; La Regina G; Silvestri R; Martini C; Marinelli L
    Eur J Pharmacol; 2021 Apr; 897():173936. PubMed ID: 33581134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SUMOylation Fine-Tunes Endothelial HEY1 in the Regulation of Angiogenesis.
    Ren R; Ding S; Ma K; Jiang Y; Wang Y; Chen J; Wang Y; Kou Y; Fan X; Zhu X; Qin L; Qiu C; Simons M; Wei X; Yu L
    Circ Res; 2024 Jan; 134(2):203-222. PubMed ID: 38166414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hey basic helix-loop-helix transcription factors are repressors of GATA4 and GATA6 and restrict expression of the GATA target gene ANF in fetal hearts.
    Fischer A; Klattig J; Kneitz B; Diez H; Maier M; Holtmann B; Englert C; Gessler M
    Mol Cell Biol; 2005 Oct; 25(20):8960-70. PubMed ID: 16199874
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The
    Fukusumi T; Guo TW; Sakai A; Ando M; Ren S; Haft S; Liu C; Amornphimoltham P; Gutkind JS; Califano JA
    Clin Cancer Res; 2018 Feb; 24(3):619-633. PubMed ID: 29146722
    [No Abstract]   [Full Text] [Related]  

  • 51. Norrin mediates tumor-promoting and -suppressive effects in glioblastoma via Notch and Wnt.
    El-Sehemy A; Selvadurai H; Ortin-Martinez A; Pokrajac N; Mamatjan Y; Tachibana N; Rowland K; Lee L; Park N; Aldape K; Dirks P; Wallace VA
    J Clin Invest; 2020 Jun; 130(6):3069-3086. PubMed ID: 32182224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HEY1 is expressed independent of NOTCH1 and is associated with poor prognosis in head and neck squamous cell carcinoma.
    Rettig EM; Bishop JA; Agrawal N; Chung CH; Sharma R; Zamuner F; Li RJ; Koch WM; Califano JA; Guo T; Gaykalova DA; Fakhry C
    Oral Oncol; 2018 Jul; 82():168-175. PubMed ID: 29909892
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme.
    Qiu S; Huang D; Yin D; Li F; Li X; Kung HF; Peng Y
    Biochim Biophys Acta; 2013 Oct; 1832(10):1697-707. PubMed ID: 23707559
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel LncRNA OXCT1-AS1 indicates poor prognosis and contributes to tumorigenesis by regulating miR-195/CDC25A axis in glioblastoma.
    Zhong C; Yu Q; Peng Y; Zhou S; Liu Z; Deng Y; Guo L; Zhao S; Chen G
    J Exp Clin Cancer Res; 2021 Apr; 40(1):123. PubMed ID: 33832517
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Doxorubicin Inhibits Proliferation of Osteosarcoma Cells Through Upregulation of the Notch Signaling Pathway.
    Ji P; Yu L; Guo WC; Mei HJ; Wang XJ; Chen H; Fang S; Yang J
    Oncol Res; 2014; 22(4):185-191. PubMed ID: 26351207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
    Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
    Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transcription factor 3 controls cell proliferation and migration in glioblastoma multiforme cell lines.
    Li R; Li Y; Hu X; Lian H; Wang L; Fu H
    Biochem Cell Biol; 2016 Jun; 94(3):247-55. PubMed ID: 27105323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of miR-21 signaling by MPS1 in human glioblastoma.
    Maachani UB; Tandle A; Shankavaram U; Kramp T; Camphausen K
    Oncotarget; 2016 Aug; 7(33):52912-52927. PubMed ID: 25991676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.
    Giachino C; Boulay JL; Ivanek R; Alvarado A; Tostado C; Lugert S; Tchorz J; Coban M; Mariani L; Bettler B; Lathia J; Frank S; Pfister S; Kool M; Taylor V
    Cancer Cell; 2015 Dec; 28(6):730-742. PubMed ID: 26669487
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
    Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X
    Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.